RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Oladapo Bakare to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Oladapo Bakare has written about Dose-Response Relationship, Drug.
Oladapo Bakare
Connection Strength
0.031
Dose-Response Relationship, Drug
  1. Akinboye ES, Rosen MD, Bakare O, Denmeade SR. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives. Bioorg Med Chem. 2017 12 15; 25(24):6707-6717.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support